Drug Toxicity Testing
Drug Toxicity Testing - Related Videos
09:49
Kupffer Cell Isolation for Nanoparticle Toxicity Testing
0 Views •
Cited by 28 •
2015
Liver macrophages, named Kupffer cells, are responsible for the capture of circulating nanoparticles. We describe here a method, of high cell purity and yield, for Kupffer cell isolation. The modified LDH assay is used here to measure the toxicity induced by carbon nanotubes in Kupffer cells.
01:23
Toxicity Testing in Animals
0 Views •
2026
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:30
Drug toxicity: Drug–Drug Interaction
0 Views •
2026
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:00
Drug Toxicity: Overview
0 Views •
2026
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
05:44
In vitro Cell Culture Model for Toxic Inhaled Chemical Testing
0 Views •
Cited by 25 •
2014
This protocol is designed to demonstrate exposure method of cell cultures to inhaled toxic chemicals. Exposure of differentiated air-liquid interface (ALI) cultures of airway epithelial cells provides a unique model of airway exposure to toxic gases such as chlorine. In this manuscript we describe effect of chlorine exposure on air-liquid interface cultures of epithelial cells and submerged culture of cardiomyocytes. In vitro exposure systems allow important mechanistic studies to evaluate...
FAQs
A dose-response relationship shows how the magnitude of harm changes as exposure concentration increases. Researchers compare several defined concentrations rather than relying on a single treatment level, which helps identify thresholds or exposure ranges associated with cellular, tissue, or organ effects. This pattern supports compound comparison, dose planning, and interpretation of whether observed injury is concentration-dependent.
Different endpoints provide evidence about distinct types of injury. Cell viability indicates whether cells remain functional, while membrane damage can reveal loss of structural integrity. Enzyme activity may signal altered cellular processes, genetic injury can indicate effects on biological material, and organ-function measurements show consequences at a larger biological scale. Using multiple endpoints can clarify the nature of toxicity.
Untreated controls establish the baseline condition against which exposed systems are evaluated. Comparing treated and untreated samples helps distinguish compound-related changes from normal variation or effects caused by the experimental system itself. Interpretation also depends on the selected concentration and exposure duration, because the same compound may produce different outcomes under different testing conditions.
Cultured cells can provide focused information about cellular viability, membrane damage, enzyme activity, or genetic injury. Tissue models add interactions among organized biological structures, whereas whole-organism studies can reveal changes in organ function. These systems offer different levels of biological context, so findings from one model may not fully represent responses in another.
A typical workflow selects a model system, exposes it to defined compound concentrations for specified durations, and includes untreated controls for comparison. Researchers then measure relevant outcomes, such as viability, membrane damage, enzyme activity, genetic injury, or organ function. Finally, they examine the response pattern to support compound selection, risk assessment, or dose planning.
The results help researchers identify compounds that produce harmful effects before advancing them, compare candidate safety profiles, and plan doses for subsequent studies. They also contribute to risk assessment by showing how biological systems respond under defined exposure conditions. Because model systems have limitations, conclusions should account for whether the tested cells, tissues, or organisms reflect the intended biological context.